FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/12/2025
Voltar para busca
Dado oficial do USPTO
HELAXA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 3, 5, 42
Data de depósito
03/12/2022
Data de registro
30/09/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/09/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
DE
Examinador
BODRI, KRISTIN MARIE
Unidade examinadora
L50
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized wording "HELAXA" with the letters "HELA" in blue, "X" with the left half in orange and the right half in pink with purple shading, and the last "A" in blue, all on a transparent background.
Titulares e representantes
Titulares
Helaxa GmbH & Co. KG
Representantes
KATRIN LEWERTOFF LEWERTOFF IP LAW GROUP, LLC
Classificação técnica
Classes Nice
Classe 1Classe 3Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and science; biological preparations for use in industry and science; all the aforementioned goods not in relation to food and food production
Classe 3
Non- medical cosmetics
Classe 5
Pharmaceuticals, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medical preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; veterinary preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; pharmaceutical preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicinal healthcare preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicinal preparations and substances, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicines for human purposes, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicines for veterinary purposes, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; nutritional supplements for human purposes; nutritional supplements for veterinary use; dietetic foods adapted for medical purposes
Classe 42
Scientific and technological services and research and design relating thereto, namely, scientific research in the medical and pharmaceutical fields and design relating thereto, namely, design and testing of new products for others; industrial analysis and research services in the medical and pharmaceutical fields; industrial design; research and development of new products for others; medical research services; technical research services in the medical and pharmaceutical fields; quality control for others; chemical analysis; medical and scientific research, namely, conducting clinical trials for others; chemical laboratories; technological research in the medical and pharmaceutical fields; scientific research
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/11/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
24/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/09/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
30/09/2025
TMBN
TTAB RELEASE CASE TO TRADEMARKS
09/09/2025
OP.T
OPPOSITION TERMINATED NO. 999999
09/09/2025
OP.D
OPPOSITION DISMISSED NO. 999999
09/09/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/09/2025
RFNP
REFUSAL PROCESSED BY IB
01/03/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
03/02/2025
OP.I
OPPOSITION INSTITUTED NO. 999999
03/02/2025
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
01/02/2025
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
01/02/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
20/09/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/09/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2024
PUBO
PUBLISHED FOR OPPOSITION
06/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2024
RFNP
REFUSAL PROCESSED BY IB
26/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/03/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/02/2024
GNRT
NON-FINAL ACTION E-MAILED
26/02/2024
CNRT
NON-FINAL ACTION WRITTEN
26/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2024
RFNT
REFUSAL PROCESSED BY IB
25/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/09/2023
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
29/09/2023
RFRR
REFUSAL PROCESSED BY MPU
29/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/09/2023
CNRT
NON-FINAL ACTION WRITTEN
15/09/2023
DOCK
ASSIGNED TO EXAMINER
12/09/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
14/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/04/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/04/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HELAXA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.